These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 38259757)

  • 1. Vivax malaria: a possible stumbling block for malaria elimination in India.
    Kumar A; Singh PP; Tyagi S; Hari Kishan Raju K; Sahu SS; Rahi M
    Front Public Health; 2023; 11():1228217. PubMed ID: 38259757
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review.
    Drysdale M; Tan L; Martin A; Fuhrer IB; Duparc S; Sharma H
    Infect Dis Ther; 2023 Jan; 12(1):33-51. PubMed ID: 36378465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of relapsing Plasmodium vivax malaria.
    Chu CS; White NJ
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
    Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
    Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of G6PD testing and primaquine for
    Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
    WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax - How hidden reservoirs hinder global malaria elimination.
    Angrisano F; Robinson LJ
    Parasitol Int; 2022 Apr; 87():102526. PubMed ID: 34896312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control and elimination of Plasmodium vivax.
    Shanks GD
    Adv Parasitol; 2012; 80():301-41. PubMed ID: 23199491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
    Milligan R; Daher A; Graves PM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium vivax in the Era of the Shrinking P. falciparum Map.
    Price RN; Commons RJ; Battle KE; Thriemer K; Mendis K
    Trends Parasitol; 2020 Jun; 36(6):560-570. PubMed ID: 32407682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for malaria treatment evaluation in the presence of multiple species.
    Walker CR; Hickson RI; Chang E; Ngor P; Sovannaroth S; Simpson JA; Price DJ; McCaw JM; Price RN; Flegg JA; Devine A
    Epidemics; 2023 Sep; 44():100687. PubMed ID: 37348379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency.
    Chamchod F; Beier JC
    J Theor Biol; 2013 Jan; 316():25-34. PubMed ID: 22959914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.
    Ebstie YA; Abay SM; Tadesse WT; Ejigu DA
    Drug Des Devel Ther; 2016; 10():2387-99. PubMed ID: 27528800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
    He X; Pan M; Zeng W; Zou C; Pi L; Qin Y; Zhao L; Qin P; Lu Y; Baird JK; Huang Y; Cui L; Yang Z
    BMC Infect Dis; 2019 Aug; 19(1):704. PubMed ID: 31399061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.